BBT Biotech Gmbh — FDA Facility Profile

FEI 3005761912

BBT Biotech Gmbh is an FDA-inspected facility (FEI 3005761912) located in Baesweiler, DE. RegDataLab tracks 1 FDA inspection and 1 compliance action at this facility.

Reviewing BBT Biotech Gmbh as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check BBT Biotech Gmbh yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
May 7, 2015: Official Action Indicated (OAI)
Inspections on record
1 (1 OAI)
Last OAI inspection
May 7, 2015
Warning letters
1 listed by FDA for this FEI, latest May 16, 2016
Import refusals
3

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 7, 2015Official Action Indicated (OAI)No citations listed

Facility details

Company
BBT Biotech Gmbh
Location
Baesweiler (DE)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.